Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Niflumic acid (CAS 4394-00-7)

5.0(1)
Write a reviewAsk a question

See product citations (3)

Alternate Names:
Landruma
Application:
Niflumic acid is a selective Cox-2 inhibitor and GPR35 activator
CAS Number:
4394-00-7
Purity:
>99%
Molecular Weight:
282.22
Molecular Formula:
C13H9F3N2O2
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Niflumic acid is a selective inhibitor of Cox-2 (cyclooxygenase-2). Niflumic acid acts as a potent anion channel blocker and GPR35 activator. Niflumic acid, a carboxylic acid derivative, has been examined in vitro using various cell lines, including those derived from human cancers. It has demonstrated significant efficacy in inhibiting the proliferation of cancer cells while also inducing apoptosis, a programmed cell death mechanism.


Niflumic acid (CAS 4394-00-7) References

  1. Thermodynamic origin of the solubility profile of drugs showing one or two maxima against the polarity of aqueous and nonaqueous mixtures: niflumic acid and caffeine.  |  Bustamante, P., et al. 2002. J Pharm Sci. 91: 874-83. PMID: 11920772
  2. Direct block of the cystic fibrosis transmembrane conductance regulator Cl(-) channel by niflumic acid.  |  Scott-Ward, TS., et al. 2004. Mol Membr Biol. 21: 27-38. PMID: 14668136
  3. Cl- channel blockers NPPB and niflumic acid blunt Ca(2+)-induced erythrocyte 'apoptosis'.  |  Myssina, S., et al. 2004. Cell Physiol Biochem. 14: 241-8. PMID: 15319527
  4. Niflumic acid suppresses interleukin-13-induced asthma phenotypes.  |  Nakano, T., et al. 2006. Am J Respir Crit Care Med. 173: 1216-21. PMID: 16528019
  5. Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.  |  White, MM. and Aylwin, M. 1990. Mol Pharmacol. 37: 720-4. PMID: 1692608
  6. Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas.  |  Gögelein, H., et al. 1990. FEBS Lett. 268: 79-82. PMID: 1696554
  7. Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: the role of hCLCA1.  |  Hegab, AE., et al. 2007. Chest. 131: 1149-56. PMID: 17426222
  8. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.  |  Miners, JO., et al. 2011. Drug Metab Dispos. 39: 644-52. PMID: 21245288
  9. Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid.  |  Takács-Novák, K., et al. 2013. J Pharm Biomed Anal. 83: 279-85. PMID: 23770783
  10. Cobinding of Pharmaceutical Compounds at Mineral Surfaces: Mechanistic Modeling of Binding and Cobinding of Nalidixic Acid and Niflumic Acid at Goethite Surfaces.  |  Xu, J., et al. 2017. Environ Sci Technol. 51: 11617-11624. PMID: 28902498
  11. Electrospun nanofiber-based niflumic acid capsules with superior physicochemical properties.  |  Radacsi, N., et al. 2019. J Pharm Biomed Anal. 166: 371-378. PMID: 30711806
  12. Silver(I) complexes containing diclofenac and niflumic acid induce apoptosis in human-derived cancer cell lines.  |  Altay, A., et al. 2022. Arch Physiol Biochem. 128: 69-79. PMID: 31516039
  13. Purification and characterization of prostaglandin H synthase-2 from sheep placental cotyledons.  |  Johnson, JL., et al. 1995. Arch Biochem Biophys. 324: 26-34. PMID: 7503555
  14. Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system.  |  Barnett, J., et al. 1994. Biochim Biophys Acta. 1209: 130-9. PMID: 7947975
  15. Effect of niflumic acid on noradrenaline-induced contractions of the rat aorta.  |  Criddle, DN., et al. 1996. Br J Pharmacol. 118: 1065-71. PMID: 8799583

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Niflumic acid, 5 g

sc-204820
5 g
$31.00

What is the appearance of the compound?

Asked by: two2igm05
Thank you for your question. This chemical is supplied as a pale yellow powder. Please contact Technical Service if you have further questions concerning this product.
Answered by: Tech Service 9
Date published: 2017-01-23
  • y_2025, m_11, d_13, h_10CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_204820, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 109ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from StregeStrege, et al. (PubMed ID 26359375) found that niflumic acid, a CACC inhibitor, inhibited the calcium current with greater efficiency and exhibited a higher potency against Ano1(+0)when compared to Ano1(-0). -SCBT Publication Review
Date published: 2015-03-12
  • y_2025, m_11, d_13, h_10
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_204820, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 17ms
  • REVIEWS, PRODUCT
Niflumic acid is rated 5.0 out of 5 by 1.
  • y_2025, m_11, d_13, h_10
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_204820, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 100ms
  • REVIEWS, PRODUCT